AndroidMediaCell

News Updates (18)

CapMan Buyout Appoints Maija Joutsenkoski as Partner: A Key Leader with Decade-Long Industry and Private Equity Experience

Helsinki-based private equity firm CapMan Buyout has announced the appointment of Maija Joutsenkoski as Partner, effective April 1st. Ms. Joutsenkoski, who joined the company in 2022, has demonstrated her leadership skills and strong drive during her short tenure, making her a valuable addition to the team.   A Decade-Long Experience in Private Equity and Industry…

Read More
News Updates (1)

SLP Signs Agreement with Beulco Group for Lease Extension and Expansion

Swedish real estate firm SLP has signed an agreement with the Beulco Group, extending and expanding the existing lease for properties in Helsingborg. The family-owned company, Beulco Holding, has operated in the properties since 1988. The extension includes a new construction of approximately 1,000 square meters, increasing the total lettable area to 5,300 square meters….

Read More
News Updates (14)

Karolinska Institutet to confer Honorary Doctorates to Two Distinguished Individuals

Karolinska Institutet, a world-renowned medical university in Stockholm, Sweden, has announced that it will confer honorary doctorates to two individuals for their outstanding contributions to the field of medicine. The formal ceremony will take place at Stockholm City Hall on 12 May, as part of the doctoral conferment ceremony.   Pioneering Geriatric Medicine Specialist to…

Read More
News Updates (8)

Bactiguard’s Launch of Wound Care Product Range in UK and Ireland

Infection prevention solutions provider Bactiguard has collaborated with Quintess Medical and GS Medical to launch its wound care products in the UK and Ireland. The company’s wound care range includes biocompatible and effective wound care products that are pH-neutral and support an improved wound healing process. The Bactiguard product line is also environmentally friendly and…

Read More
News Updates (18)

Aqilion and Merck Partner to Develop Groundbreaking Treatments for Chronic Inflammation

Swedish biotech firm Aqilion has partnered with global pharmaceutical company Merck to develop new treatments for chronic inflammation and immune dysfunction. The strategic collaboration will focus on discovering and commercializing inhibitors of the TAK1 protein, which is a crucial mediator in the inflammatory process. Merck’s upfront cash payment of EUR 10 million to Aqilion is…

Read More